Sun Pharma’s foreign unit Taro posts 26% growth in Q3 net

Taro Pharma’s net profit rises to $87 mn from $69 mn in the corresponding year-ago period
Comment E-mail Print Share
First Published: Tue, Feb 05 2013. 12 57 PM IST
Sun Pharma’s Taro, in a late Monday statement, said price increases helped improve revenue and profit as there was actually a drop in volumes in the December quarter. Photo: Hemant Mishra/Mint
Sun Pharma’s Taro, in a late Monday statement, said price increases helped improve revenue and profit as there was actually a drop in volumes in the December quarter. Photo: Hemant Mishra/Mint
Updated: Tue, Feb 05 2013. 02 19 PM IST
Mumbai: Taro Pharmaceutical Industries Ltd, the Israel-based subsidiary unit of Sun Pharmaceutical Industries Ltd, has posted a 26% increase in net profit for the October-December quarter.
Taro, which announced its third-quarter earnings on Monday, said its net profit rose to $87 million from $69 million in the corresponding year-earlier period. Sales grew 25.4% to $186 million boosted by an increase in prices of some products in the US.
Sun Pharma holds a 66% stake in Taro. The Israel-based unit contributed about 32% of Sun Pharma’s revenue in fiscal 2012.
Taro, in a late Monday statement, said price increases helped improve revenue and profit as there was actually a drop in volumes in the December quarter.
“Taro’s excellent performance will greatly reflect in Sun Pharma results, which is expected to post an increase of at least 25% in the third-quarter profits,” said an industry analyst with a foreign brokerage, declining to be named.
Sun’s shares were trading 4% higher at Rs.747.90 each on BSE in late morning trade, while the Sensex was down 0.30% at 19,691.25 points.
Comment E-mail Print Share
First Published: Tue, Feb 05 2013. 12 57 PM IST
blog comments powered by Disqus
  • Wed, Oct 22 2014. 09 49 PM
  • Wed, Oct 15 2014. 11 40 PM
Subscribe |  Contact Us  |  mint Code  |  Privacy policy  |  Terms of Use  |  Advertising  |  Mint Apps  |  About HT Media  |  Jobs
Contact Us
Copyright © 2014 HT Media All Rights Reserved